ARTICLE | Distillery Therapeutics
Therapeutics: κ opioid receptor (KOR; OPRK1); opioid receptor δ 1 (OPRD1; DOR)
June 18, 2015 7:00 AM UTC
In vitro and mouse studies suggest diimidazodiazepine-based dual KOR/DOR agonists could help treat pain with fewer side effects than standard opiates. In vitro testing of fused diimidazodiazepine anal...